We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Trichinellosis Is Unlikely to Be Responsible for Mozart's Death

Jean Dupouy-Camet, MD, PhD
Arch Intern Med. 2002;162(8):946. doi:.
Text Size: A A A
Published online


Hirschmann,1 in his stimulating and fascinating article "What Killed Mozart," suggests that trichinellosis (trichinosis) could explain the death of this eminent composer. This parasitic disease, though unrecognized, was certainly common in central Europe at the end of the 18th century. The parasite was identified in London in 18352 (and not in 1825 as stated by Hirschmann ...) but its clinical relevance was only assessed in 1860 in Dresden. As a matter of fact, more than 80 outbreaks of trichinellosis were reported between 1858 and 1882 in this area3(p130) and, particularly, 2 outbreaks were described in Vienna in 1881 and 1882. Interestingly, this parasitosis is still prevalent in central European countries (Poland, Romania, Balkans, Baltic republics, Russia) where outbreaks are reported among pork eaters.4 As mentioned by Hirschmann, many medical causes could have explained Mozart's death but, in my opinion, the major features reported in his article are not particularly suggestive of trichinellosis. I was involved with 3 major outbreaks in France that included 1611 patients5,6 and the most prominent clinical features of the acute phase of the disease were myalgias (82%-93%), fever (81%-90%), and facial and eyelid edema (58%-84%). Cutaneous rash was reported in 11% to 44% of the cases and limb edema in 6% to 8%. Severe forms were characterized by the occurrence of neurologic complications (encephalitis), which were observed in 1.4% to 9% of the patients. Five patients died of thromboembolic complications or encephalitis. If Mozart had been affected by a severe course of trichinellosis, he certainly would have presented myalgia, probably a facial edema, and may have experienced neurologic complications preventing him to compose his Requiem mass. These important symptoms are not reported by Hirschmann. Myalgia, sometimes excruciating, is one of the most frequent symptoms of trichinellosis and affects preferentially the masseters, the tongue, the muscles of the neck, the flexor muscles of the extremities, and the muscles of the back. Walking and speaking can be difficult. Myalgia is absent only in very mild cases with an excellent prognosis. Myalgias were also prominent features in the first human observation described by Zenker in 1860,1 which was at first mistaken for typhoid fever. In addition, if limb edema can be seen, inflammation of extremities including hands and feet is not a sign of trichinellosis. Finally, it is true that trichinellosis is an "epidemic disorder characterized in the past by a substantial mortality rate" but this disease does not have a predictable course, as in our experience the 5 deaths we reported in 1985 were relatively sudden and unexpected. Moreover, in Mozart's time, trichinellosis was not recognized as a specific entity, so how could physicians have predicted a fatal outcome to an unknown condition? Present criteria to define a case of trichinellosis include biological criteria (a positive serologic or muscular biopsy result, high eosinophil counts) associated with at least 1 of the following symptoms: fever, facial edema, and myalgias. By these criteria, it is unlikely that Mozart was affected by trichinellosis.



Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles